Comparison between Kronox Lab Sciences IPO and Stanley Lifestyles IPO.
Kronox Lab Sciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Stanley Lifestyles IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Kronox Lab Sciences IPO is up to ₹130.15 Cr whereas the issue size of the Stanley Lifestyles IPO is up to ₹537.02 Cr. The final issue price of Kronox Lab Sciences IPO is ₹136.00 per share and of Stanley Lifestyles IPO is ₹369.00 per share.
| Kronox Lab Sciences IPO | Stanley Lifestyles IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹129.00 per share | ₹351.00 per share |
| Issue Price (Upper) | ₹136.00 per share | ₹369.00 per share |
| Issue Price (Final) | ₹136.00 per share | ₹369.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 110 shares | 40 shares |
| Fresh Issue Size | 0 shares | 54,20,054 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹200.00 Cr |
| OFS Issue Size | 95,70,000 shares | 91,33,454 shares |
| OFS Issue Size (Amount) | up to ₹130.15 Cr | up to ₹337.02 Cr |
| Issue Size Total | 95,70,000 shares | 1,45,53,508 shares |
| Issue Size Total (Amount) | up to ₹130.15 Cr | up to ₹537.02 Cr |
Kronox Lab Sciences IPO opens on Jun 03, 2024, while Stanley Lifestyles IPO opens on Jun 21, 2024. The closing date of Kronox Lab Sciences IPO and Stanley Lifestyles IPO is Jun 05, 2024, and Jun 25, 2024, respectively.
| Kronox Lab Sciences IPO | Stanley Lifestyles IPO | |
|---|---|---|
| Anchor Bid Date | May 31, 2024 | Jun 20, 2024 |
| Issue Open | Jun 03, 2024 | Jun 21, 2024 |
| Issue Close | Jun 05, 2024 | Jun 25, 2024 |
| Basis Of Allotment (Tentative) | Jun 06, 2024 | Jun 26, 2024 |
| Initiation of Refunds (Tentative) | Jun 07, 2024 | Jun 27, 2024 |
| Credit of Share (Tentative) | Jun 07, 2024 | Jun 27, 2024 |
| Listing date (Tentative) | Jun 10, 2024 | Jun 28, 2024 |
| Anchor Lockin End date 1 | Jul 06, 2024 | Jul 26, 2024 |
| Anchor Lockin End date 2 | Sep 04, 2024 | Sep 24, 2024 |
Kronox Lab Sciences IPO P/E ratio is 30.37, as compared to Stanley Lifestyles IPO P/E ratio of 54.43.
| Kronox Lab Sciences IPO | Stanley Lifestyles IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.98 | 67.36 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.21 | 56.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 30.37 | 54.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹504.61 Cr. | ₹2103.94 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 25.66% | 7.92% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 33.15% | 8.63% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.48 | ₹6.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 25.66% | 8.34% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Kronox Lab Sciences IPO Retail Individual Investors (RII) are offered 33,49,500 shares while in Stanley Lifestyles IPO retail investors are offered 33,49,500 shares. Qualified Institutional Buyers (QIB) are offered 19,14,000 shares in Kronox Lab Sciences IPO and 29,10,702 shares in Stanley Lifestyles IPO.
| Kronox Lab Sciences IPO | Stanley Lifestyles IPO | |
|---|---|---|
| Anchor Investor Reservation | 28,71,000 shares | 43,66,051 shares |
| Market Maker Reservation | ||
| QIB | 19,14,000 shares | 29,10,702 shares |
| NII | 14,35,500 shares | 21,83,027 shares |
| RII | 33,49,500 shares | 50,93,728 shares |
| Employee | ||
| Others | ||
| Total | 95,70,000 shares | 1,45,53,508 shares |
Kronox Lab Sciences IPO subscribed 117.25x in total, whereas Stanley Lifestyles IPO subscribed 97.16x.
| Kronox Lab Sciences IPO | Stanley Lifestyles IPO | |
|---|---|---|
| QIB (times) | 89.03x | 215.62x |
| NII (times) | 301.92x | 121.42x |
| Big NII (times) | 322.26x | 136.75x |
| Small NII (times) | 261.22x | 90.76x |
| RII (times) | 54.24x | 19.08x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 117.25x | 97.16x |
